Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$618.46 USD

618.46
1,324,097

-5.75 (-0.92%)

Updated Sep 11, 2024 04:00 PM ET

After-Market: $618.47 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Align's (ALGN) ClinCheck Suite Now Commercially Available

Align Technology's (ALGN) ClinCheck treatment-planning software's commercial availability is expected to boost doctor performances due to ready availability of treatment plans.

Thermo Fisher Scientific (TMO) Q3 Earnings and Revenues Beat Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 28.83% and 10.03%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights include: DKS, ATVI, TMO, FBHS and TSM

Zacks.com featured highlights include: DKS, ATVI, TMO, FBHS and TSM

Intersect ENT (XENT) Posts Preliminary Q3 Data, Dull Q4 View

Intersect ENT (XENT) expects the strength in its product lines to have substantially boosted revenues in the third quarter.

Baxter Supports Findings of Ongoing COVID-19 Nutrition Study

The study, supported by Baxter (BAX) through an investigator-initiated grant, is the first analysis of longitudinal REE in critically ill, mechanically-ventilated COVID-19 patients.

Here's Why You Should Invest in AmerisourceBergen (ABC) Now

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

LHC Group (LHCG) and CHRISTUS Health Extend JV Partnership

LHC Group (LHCG) and CHRISTUS Health expand their partnership to boost home health services and hospice care.

Sweta Killa headshot

Forget Market Volatility With These Dividend Growth Stocks

Zeroing in on companies that not only offer dividends but also consistently increase their payouts seems like a good idea.

Thermo Fisher (TMO) Hits 52-Week High, Can the Run Continue?

Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here's Why You Should Retain Accuray (ARAY) Stock for Now

Investors' confidence is high in the Accuray (ARAY) stock, thanks to its solid prospects.

Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.

Allscripts Completes Sale of EPSi Business to Strata

Allscripts (MDRX) completes the sale of its EPSi business to Strata. Notably, the combination of two companies can reduce cost associated with healthcare.

Boston Scientific Gets a Boost From MedSurg Arm Amid Coronavirus

Within Endoscopy, Boston Scientific (BSX) believes that business recovery started since June.

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?

Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thermo Fisher (TMO) to Report Q3 Earnings: What's in Store?

In the third quarter, Thermo Fisher (TMO) invests more than $140 million to increase the production of its laboratory plastic consumables.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

Nevro (NVRO) continues to gain traction from its flagship platform, Senza, and R&D capabilities. However, stiff competition remains a woe.

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $467.53, moving +0.17% from the previous trading session.

The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher

The Zacks Analyst Blog Highlights: Emergent BioSolutions, Vertex Pharmaceuticals, Editas Medicine, Cellectis and Thermo Fisher

Abbott's New Antibody Test Gets FDA's EUA, Test Suite Expands

Abbott's (ABT) latest antibody test is expected to give a clearer picture of the rate of recovery post coronavirus infection.

Here's Why You Should Add AngioDynamics to Your Portfolio Now

Investor confidence is high in AngioDynamics (ANGO) stock, thanks to solid prospects.

Here's Why You Should Hold on to Stryker (SYK) Stock Now

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

What's in Store for Intuitive Surgical's (ISRG) Q3 Earnings?

Intuitive Surgical's (ISRG) third-quarter earnings are likely to reflect weaker-than-expected performance at Instruments & Accessories segment.

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Bruker Rides on Nano and MALDI Launches Despite Margin Debacle

Bruker (BRKR) has several Bruker NANO products that are being assembled and tested in Malaysia.

Abbott's Data From Interim Clinical Study of ID NOW Positive

Abbott's (ABT) recent data from an interim clinical study on its ID NOW COVID-19 rapid test reflects the test's capacity to deliver effective, consistent and reliable performance.